Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Starr

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
The Journal of Experimental Medicine|March 1, 1992
Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patientsJ Chehimi, S E Starr, I Frank, et al.
European Journal of Immunology|August 1, 1993
Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cellsJ Chehimi, N M Valiante, A D'Andrea, et al.
The Journal of Infectious Diseases|November 9, 2000
Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected childrenS A Spector, K Hsia, F H Yong, et al.
Archives of Pediatrics & Adolescent Medicine|April 18, 2000
T-lymphocyte subsets in HIV-infected and high-risk HIV-uninfected adolescents: retention of naive T lymphocytes in HIV-infected adolescents. The Adolescent Medicine HIV/AIDS Research NetworkS D Douglas, B Rudy, L Muenz, et al.
Annals of Internal Medicine|April 1, 1991
Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trialS A Plotkin, S E Starr, H M Friedman, et al.
Annals of Internal Medicine|November 1, 1979
Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trialJ P Glazer, H M Friedman, R A Grossman, et al.
American Journal of Diseases of Children (1960)|May 1, 1984
Varicella vaccine trials in healthy children. A summary of comparative and follow-up studiesA M Arbeter, S E Starr, S R Preblud, et al.
Transplantation|August 1, 1985
The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantationM L Smiley, C G Wlodaver, R A Grossman, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1988
Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trialK L Brayman, D C Dafoe, W R Smythe, et al.
Birth Defects Original Article Series|January 1, 1984
Prevention of cytomegalovirus disease by Towne strain live attenuated vaccineS A Plotkin, M L Smiley, H M Friedman, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Experimental Medicine|March 1, 1992
Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patientsJ Chehimi, S E Starr, I Frank, et al.
European Journal of Immunology|August 1, 1993
Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cellsJ Chehimi, N M Valiante, A D'Andrea, et al.
The Journal of Infectious Diseases|November 9, 2000
Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected childrenS A Spector, K Hsia, F H Yong, et al.
Archives of Pediatrics & Adolescent Medicine|April 18, 2000
T-lymphocyte subsets in HIV-infected and high-risk HIV-uninfected adolescents: retention of naive T lymphocytes in HIV-infected adolescents. The Adolescent Medicine HIV/AIDS Research NetworkS D Douglas, B Rudy, L Muenz, et al.
Annals of Internal Medicine|April 1, 1991
Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trialS A Plotkin, S E Starr, H M Friedman, et al.
Annals of Internal Medicine|November 1, 1979
Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trialJ P Glazer, H M Friedman, R A Grossman, et al.
American Journal of Diseases of Children (1960)|May 1, 1984
Varicella vaccine trials in healthy children. A summary of comparative and follow-up studiesA M Arbeter, S E Starr, S R Preblud, et al.
Transplantation|August 1, 1985
The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantationM L Smiley, C G Wlodaver, R A Grossman, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1988
Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trialK L Brayman, D C Dafoe, W R Smythe, et al.
Birth Defects Original Article Series|January 1, 1984
Prevention of cytomegalovirus disease by Towne strain live attenuated vaccineS A Plotkin, M L Smiley, H M Friedman, et al.
Pageof 12